Characteristics | Intervention period | Post-intervention period | ||
---|---|---|---|---|
Control (N = 37) | HIVST (N = 97) | Control (N = 37) | HIVST (N = 97) | |
N (%) | N (%) | N (%) | N (%) | |
Any testing (≥ 1 test in 12 mo.) | 28 (75.7) | 96 (99.0) | 23 (62.2) | 74 (76.3) |
Repeat testing (> 1 test in 12 mo.) | 18 (48.7) | 92 (94.9) | 11 (29.7) | 41 (42.3) |
Test types used1 | Â | Â | Â | Â |
In-person testing only | 23 (85.2) | 1 (1.0) | 13 (56.5) | 16 (21.6) |
HIVST (independently purchased) only | 3 (11.1) | 0 (0.0) | 9 (39.1) | 4 (5.4) |
HIVST (study-provided) only | 0 (0.0) | 39 (40.6) | 0 (0.0) | 34 (46.0) |
In-person & purchased HIVST | 1 (3.7) | 0 (0.0) | 1 (4.4) | 3 (4.1) |
In-person & study-provided HIVST | 0 (0.0) | 45 (46.9) | 0 (0.0) | 16 (21.6) |
Purchased & study-provided HIVST | 0 (0.0) | 4 (4.2) | 0 (0.0) | 1 (1.4) |
All three types | 0 (0.0) | 7 (7.3) | 0 (0.0) | 0 (0.0) |
Locations of in-person tests used2 | Â | Â | Â | Â |
Primary care doctor | 22 (42.3) | 31 (50.8) | 9 (40.9) | 21 (41.2) |
HIV testing clinic | 21 (40.3) | 18 (29.5) | 11 (50.0) | 13 (25.4) |
Community event | 6 (11.5) | 6 (9.8) | 2 (9.1) | 12 (23.5) |
Other medical clinic | 3 (5.8) | 6 (9.8) | 0 (0.0) | 5 (9.8) |
Other | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |